Company: BLNE
Filing Date: 2025-12-02
Form Type: S-8
Source: 0001493152-25-025742
Chunk: 1

Company: Beeline Holdings, Inc.
Filing Date: 2025-12-02
Form: S-8
Chunk 1
---
 register a total of 10,704,865 shares of Common Stock of Beeline Holdings, Inc. issued or issuable under the Beeline Holdings, Inc. Amended and Restated 2025 Equity Incentive Plan.

This Registration Statement also includes a reoffer prospectus, prepared pursuant to General Instruction C to Form S-8, in accordance with the requirements of Part I of Form S-3, to be used by the Company’s directors and executive officers (which we refer to as the “Selling Shareholders”), as described under the section entitled “Selling Shareholders” therein, in connection with reoffers and resales on a continuous or delayed basis of a total of 872,331 shares of Common Stock that have been or may be acquired by the Selling Shareholders pursuant to awards which are outstanding under the under the Plan as of the date hereof. The Selling Shareholders are considered affiliates of the Company, as defined in Rule 405 under the Securities Act, and may be selling shares of Common Stock that constitute “restricted securities” within the meaning of General Instruction C to Form S-8.

| i |

<div align='center'>PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>

ITEM 1. PLAN INFORMATION

This prospectus relates to up to 10,704,865 shares of Beeline Holdings, Inc. (“the Company”) Common Stock which have been or may be issued or issuable to employees, nonemployee directors, consultants and advisors of the Company and its subsidiaries under the Company’s 2025 Amended and Restated Equity Incentive Plan (the “Plan”). The aggregate number of shares of Common Stock which shall be available for grants or payments of awards under the Plan equals 15% of the outstanding shares of Common Stock on a fully diluted basis (the “Share Reserve”), subject to annual increase as described below.

The Plan contains an “evergreen provision,” where the Share Reserve will automatically increase on January 1st of each year (each, an “Increase Date”), for a period of seven years commencing on January 1, 2026 and ending on January 1, 2032. The yearly increases shall equal an amount equal to 5% of the total number of shares of Common Stock outstanding as of December 31 of the preceding calendar year, on a fully diluted basis. No more than an aggregate of 375,000 shares of Common Stock may be issued pursuant to the exercise of incentive stock options (“